MAP PHARMACEUTICALS, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 29 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-09-24: Reporting owner WARD SCOTT R; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-07-23: Reporting owner KELLERMAN DONALD J; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-07-23: Reporting owner KELLERMAN DONALD J; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-07-07: Reporting owner GIANAKAKOS ANASTASIOS; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-09-24 | WARD SCOTT R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $8.98 exercise price | 2008-09-26 | |
| 2008-07-23 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 0 owned after | $9.20 exercise price | 2008-07-25 | |
| 2008-07-23 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 0 owned after | $9.20 exercise price | 2008-07-25 | |
| 2008-07-07 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −600 106,643 owned after | $0.74 exercise price | 2008-07-08 | |
| 2008-07-03 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −800 107,243 owned after | $0.74 exercise price | 2008-07-07 | |
| 2008-07-02 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,200 108,043 owned after | $0.74 exercise price | 2008-07-07 | |
| 2008-07-02 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,200 108,043 owned after | $0.74 exercise price | 2008-07-07 | |
| 2008-07-01 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,900 110,243 owned after | $0.74 exercise price | 2008-07-02 | |
| 2008-06-04 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,500 114,143 owned after | $0.74 exercise price | 2008-06-05 | |
| 2008-06-03 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 117,643 owned after | $0.74 exercise price | 2008-06-04 | |
| 2008-06-02 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 120,143 owned after | $0.74 exercise price | 2008-06-03 | |
| 2008-05-22 | PEARL FRANK H 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Indirect · See footnotes | J Other acquisition or disposition (describe transaction) | +7,500 7,500 owned after | $12.19 exercise price | 2008-05-27 | |
| 2008-05-22 | SOROS GEORGE | Soros Robert | SOROS JONATHAN T ALLAN | SOROS FUND MANAGEMENT LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Stock Option (right to buy) Derivative · Indirect · See footnotes | J Other acquisition or disposition (describe transaction) | +7,500 7,500 owned after | $12.19 exercise price | 2008-05-27 | |
| 2008-05-22 | MCPHERRON MATTHEW V Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $12.19 exercise price | 2008-05-22 | |
| 2008-05-22 | Freund John Gordon Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $12.19 exercise price | 2008-05-22 | |
| 2008-05-22 | ELMS STEVE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $12.19 exercise price | 2008-05-22 | |
| 2008-05-22 | GOLDFISCHER CARL Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $12.19 exercise price | 2008-05-22 | |
| 2008-05-22 | HENWOOD GERALDINE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $12.19 exercise price | 2008-05-22 | |
| 2008-05-22 | KELLEY BERNARD J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $12.19 exercise price | 2008-05-22 | |
| 2008-05-19 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,700 124,143 owned after | $0.74 exercise price | 2008-05-20 | |
| 2008-05-16 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,300 125,843 owned after | $0.74 exercise price | 2008-05-20 | |
| 2008-05-15 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 131,143 owned after | $0.74 exercise price | 2008-05-19 | |
| 2008-03-21 | Wolff Henry Ward Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $12.74 | 2008-03-25 | |
| 2008-01-22 | SHREWSBURY STEPHEN B Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $13.12 | 2008-01-24 | |
| 2008-01-22 | GIANAKAKOS ANASTASIOS Officer (SVP, COR & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $13.12 | 2008-01-24 | |
| 2008-01-22 | NELSON TIMOTHY S Director, Officer (President and CEO, Director) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +160,000 160,000 owned after | $13.12 | 2008-01-24 | |
| 2008-01-22 | Friedman Charlene A Officer (VP President, Gen Counsel &Sec) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $13.12 | 2008-01-24 | |
| 2008-01-22 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $13.12 | 2008-01-24 | |
| 2008-01-22 | ARMER THOMAS A Director, Officer (CSO, Director) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $13.12 | 2008-01-24 |